Latest Viral nonstructural proteins Stories
New tool to help identify areas for increased education and screening for hepatitis C WASHINGTON, July 28, 2011 /PRNewswire-USNewswire/ -- In recognition of World Hepatitis Day, the National Minority Quality Forum today launched the Hepatitis C Index, a novel resource for mapping hepatitis C (http://www.maphepc.com).
ABBOTT PARK, Ill., May 18, 2011 /PRNewswire/ -- Abbott announced today that it has received approval from the U.S.
Exciting new data presented today at the International Liver CongressTM 2011 show that quadruple therapy in chronic hepatitis C (HCV) patients suppressed the emergence of resistant variants and resulted in a 100% rate of sustained virological response - undetectable HCV RNA - 12 weeks after treatment (SVR12).
BRISBANE, Calif., Jan. 5, 2011 /PRNewswire/ -- InterMune, Inc. (Nasdaq: ITMN) today announced that Dan Welch, Chairman, Chief Executive Officer and President of InterMune, will present at the 29th Annual J.P. Morgan Healthcare Conference in San Francisco on January 12, 2011, at 4:30 p.m.
In the news release, "The Hepatitis C Virus Drug Market Will Nearly Triple by 2014 but, Thereafter, the Market Will Decline Substantially Through 2019 Due to Decreasing Disease Prevalence and the High Efficacy of New Treatments, issued Nov.
PRINCETON, N.J., April 13 /PRNewswire-FirstCall/ -- Pharmasset, Inc.
PRINCETON, N.J., March 29 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (Nasdaq: VRUS) announces that management will present at the Canaccord Adams Hepatitis C Conference being held Thursday April 1, 2010 at the Peninsula Hotel, New York, NY.
WATERTOWN, Mass., March 2 /PRNewswire/ -- Enanta Pharmaceuticals, Inc. announced today the nomination of lead development candidate, EDP-239, from its NS5A hepatitis C virus (HCV) inhibitor program.